1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Taurine Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for functional food & beverages due to rising health concerns
5.1.1.2. Rising investment in drug development and manufacturing worldwide
5.1.2. Restraints
5.1.2.1. Preference for alternative natural ingredients
5.1.3. Opportunities
5.1.3.1. Advancements in the sourcing and production of taurine
5.1.3.2. Emerging utilization of taurine in pet food products
5.1.4. Challenges
5.1.4.1. Stringent regulations of taurine as a food and pharmaceutical additive
5.2. Market Segmentation Analysis
5.2.1. Grade: Growing demand for pharmaceutical grade taurine for pharmaceutical applications
5.2.2. Source: Rising adoption of natural taurine by vegetarian or vegan diet
5.2.3. Form: Expanding usage of power taurine as it provides versatility and longer shelf life
5.2.4. Application: Growing application of taurine in the food & beverage industry for producing energy and sports drinks
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Taurine Market, by Grade
6.1. Introduction
6.2. Food Grade
6.3. Pharmaceutical Grade
7. Taurine Market, by Source
7.1. Introduction
7.2. Natural
7.3. Synthetic
8. Taurine Market, by Form
8.1. Introduction
8.2. Liquid
8.3. Powder
9. Taurine Market, by Application
9.1. Introduction
9.2. Agriculture
9.3. Cosmetics & Personal Care
9.4. Food & beverages
9.5. Pharmaceuticals
10. Americas Taurine Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Taurine Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Taurine Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. Bio-Based Companies form Partnership to Sustainably Produce Taurine
13.3.2. New Product Launch & Enhancement
13.3.2.1. Discipline Industries Launches NAC, NMN, Taurine for Peak Wellness
13.3.3. Investment & Funding
13.3.3.1. TEDCO Invests in Natáur
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. A. B. Enterprises
14.1.2. Aakriti Trading Company
14.1.3. Advance Inorganics
14.1.4. Ajinomoto Co., Inc.
14.1.5. Atlantic Chemicals Trading GmbH
14.1.6. AuNutra Industries Inc.
14.1.7. Avanscure LifeSciences Pvt. Ltd.
14.1.8. AWI-Awell Ingredients Co., Ltd.
14.1.9. Foodchem International Corporation
14.1.10. Grand Pharmaceutical Group Limited
14.1.11. Hebi City Hexin Chem Ind. Co., Ltd.
14.1.12. Jiangsu Yuanyang Pharmaceutical Co., Ltd
14.1.13. Kyowa Hakko Bio Co., Ltd.
14.1.14. Mitsui Chemicals, Inc.
14.1.15. New Zealand Pharmaceuticals Limited
14.1.16. Penta Manufacturing Company
14.1.17. Qianjiang Yongan Pharmaceutical Co., Ltd.
14.1.18. Stauber Performance Ingredients, Inc.
14.1.19. Taisho Pharmaceutical Holdings Co., Ltd.
14.1.20. The Honjo Chemical Corporation
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer